22.1 The Lab Result That Names Everything

Three short movements: the case, the anatomyThe study of the structure of the human body. and physiologyThe study of how the body functions., then the tie back to Stina. Each links to the scene where you’ll see it move.

I · What page two said

In 2017 a rheumatologist ordered a periodic-fever gene panel and then left the practice. The result came back to Stina as a single word: negative. She was forty-two. She gave up chasing the fever that year. Nine years later, in April 2026, she downloaded every portal she had ever been given and fed them to a machine that asked her, mildly, whether she knew about the genetic test from when she was forty-two. It was negative, she said. It was not negative. Page two listed a variant in MEFV, the Mediterranean fever gene, and beside it a variant in LPIN2, a gene she had to look up. On 11 May 2026 a new doctor took the printout she slid across the desk, repeated the panel, and called. One MEFV variant of uncertain significance, one copy. One LPIN2 variant, one copy. No guideline covers that pairing. The doctor diagnosed familial Mediterranean fever anyway, on the fifty years of fever and serositis that had been in the chart since she was two, and started colchicine. What came was not relief. It was arithmetic.

See it move: Scene 1 · Page Two · Scene 2 · What a Panel Can and Cannot Say

II · A gene, a protein, two cells

MEFV sits on chromosome 16 and encodes pyrin, a sensor protein made almost entirely by two kinds of white blood cell: neutrophils and monocytes, the cells the Innate Cells lecture calls the microphages and the macrophages-in-waiting. Pyrin watches the inside of those cells for the chemical fingerprints of bacterial toxins; when it fires it assembles an inflammasome, and the inflammasome’s product is interleukin-1β, the fever cytokine the whole course has been tracing. The lecture’s rule holds: a gene is a recipe, a protein is the tool, and the cell that makes the tool is where the disease will live. FMF is a disease of neutrophils, which is why the fluid tapped from an FMF belly or chest is thick with them, and why a normal appendixA small, finger-like pouch attached to the cecum, thought to play a role in immune function. removed at fifteen read “unremarkable” on the slide — the cells had come and gone. A panel reports what it sequenced in three bins: pathogenic, benign, and the vast middle, variant of uncertain significance, where MEFV keeps an unusually large share of its catalogue. About 30% of people with classic FMF have no identifiable mutationA change in DNA sequence that can affect gene function. on a standard panel, which is why the Tel-Hashomer criteria are built from fevers, serositis, amyloidosis and the colchicine response, and not from a sequence. Her second gene, LPIN2, is the Majeed-syndrome gene; one copy usually causes nothing. The case’s working hypothesis — the story’s, not a published finding — is that two half-expressed diseases amplified each other for forty-nine years.

See it move: Scene 3 · The Protein Behind the Gene · Scene 5 · Four Lines That Point One Way

III · Four lines that point one way

Set beside the gene, four lines on the chart are the real evidence, and this module is built to read them. Serology: ANA, rheumatoid factor and anti-dsDNA negative every time — no autoantibody, ever. Cultures: sterile during every flare, and antibiotics never shortened one. Lymphoid tissue: nodes that swell and ache during a flare and shrink back after, a spleen a little enlarged that has never failed to clear a thing. Flares: abrupt, stereotyped, fever-first, twelve to seventy-two hours, then nothing. Together they say the adaptive arm of the immune system is not attacking her, and the innate arm is firing without a target. The chapters that follow build both arms, their cells and their organs, so that by Chapter 7 those four lines read as a fingerprint.

See it move: Scene 4 · Two Cells on a Smear · Scene 5 · Four Lines That Point One Way

5 scenes. Each one has a short animation or a slide, something to explore, a true/false spot-check of your thinking, and a quick check. Every scene gives you an evidence card for your board.

Every scene gave you an evidence card, and the chart adds more. Sort each card into the column it supports: A clinical diagnosis the gene explains, Neither on its own, or An inconclusive panel, an inconclusive patient. Some cards can honestly go in more than one place — that’s allowed, and the feedback tells you which cards decide the case.

Time to decide. Look back at your bet, then build your verdict from statements that hold up — no writing needed.